You are here: Industry Insights > CanSino

News List

CanSino Biologics Gets OGYÉI GMP Certificate for COVID Vax contractpharma
May 25, 2021
CanSino Biologics Recombinant Novel Coronavirus Vaccine, (Adenovirus Type 5 Vector, trade name Convidecia), has been granted a Good Manufacturing Practice certificate by the Hungarian National Institute of Pharmacy and Nutrition (OGYÉI).
CanSino Biologics to start clinical trials of inhaled Covid-19 vaccine pharmaceutical-technology
April 21, 2021
Chinese company CanSino Biologics is set to commence clinical trials of a Covid-19 vaccine that can be administered through inhalation.
China approves clinical trials for Livzon Pharma unit’s COVID-19 vaccine expresspharma
March 25, 2021
China’s medical products regulator has approved clinical trials for a COVID-19 vaccine candidate developed by a subsidiary of Livzon Pharmaceutical Group, the Chinese company said late on Tuesday.
CanSino’s Covid-19 vaccine receives approval in Hungary for emergency use pharmaceutical-technology
March 22, 2021
The Hungarian National Institute of Pharmacy and Nutrition has granted approval for the emergency use of Chinese company CanSino Biologics’ Covid-19 vaccine.
CanSino gets COVID-19 vaccine patent from China’s IP regulator expresspharma
August 18, 2020
CanSino Biologics has won a patent approval from Beijing for its COVID-19 vaccine candidate Ad5-nCOV, reported state media, citing documents from the country’s intellectual property regulator.
CanSino to commence Phase III COVID-19 vaccine trial in Saudi Arabia expresspharma
August 11, 2020
The vaccine uses adenovirus type-5 (Ad5) to carry genetic material from the coronavirus into the body.
China’s CanSino in talks for COVID vaccine Phase III trial overseas expresspharma
July 13, 2020
Phase III trials were likely to start “pretty soon,” and the company plans to recruit 40,000 participants for the tests.
‘At war time speed’, China leads COVID-19 vaccine race expresspharma
July 08, 2020
Sinovac Biotech’s experimental vaccine set to become the country’s second and the world’s third to enter final stage testing later this month.
China's CanSino Bio advances COVID-19 vaccine into phase 2 on preliminary safety data Fiercepharma
April 13, 2020
In the global race to develop an effective vaccine to protect people against the novel coronavirus, China’s CanSino Bio has leapt ahead.